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TO THE EDITOR
Recently, a distinct effector T helper
(Th) cell subset, Th9, was described.
These cells were generated by in vitro
culture in the presence of IL-4 and
transforming growth factor-b, and pro-
duced IL-9 and IL-10, but not IL-4, IL-5,
IL-13, IFN-g, or IL-17 (Dardalhon et al.,
2008; Veldhoen et al., 2008). The
transcription factor PU.1 and IFN reg-
ulatory factor 4 are required for the
development of Th9 cells (Chang et al.,
2010; Staudt et al., 2010). Th9 cells
have unique IL-9 expression kinetics;
IL-9 is produced rapidly, reaches a peak
on day 3 of culture, and rapidly
declines thereafter (Tan et al., 2010).
Using an adoptive transfer system, Th9
cells were shown to induce inflamma-
tion (Dardalhon et al., 2008). However,
generation of Th9 cells in vivo has yet
to be reported.
Epicutaneous sensitization with pro-
tein antigen induces predominantly
Th2, weak Th1, and modest Th17
responses. Thus, we sought to deter-
mine whether Th9 cells were generated
in vivo after epicutaneous sensitization.
All animal experiments were approved
by the animal care committee of the
Chang Gung Memorial Hospital. BALB/c
mice were administered with ovalbu-
min (OVA; 100 mg ml–1, 20 ml per
patch) successively by daily patch
application on days 1–5. Draining
lymph node cells were harvested 10
days later and used for in vitro OVA
(100mg ml–1) reactivation cultures for
48 hours. IL-9 concentrations in super-
natants were determined by ELISA. As
shown in Figure 1a, cells from BALB/c
mice that received OVA, but not
phosphate-buffered saline (PBS), by
patch application produced a signifi-
cant amount of IL-9 in vitro. We then
analyzed the IL-9 contents of super-
natants for in vitro OVA reactivation
cultures using lymph node cells from
mice that had patch applications of
OVA plus various Toll-like receptor
ligands including Pam3CSK4, polyino-
sinic-polycytidylic acid, lipopolysac-
charide, flagellin, imiquimod, and
CpG oligodeoxynucleotide. Varying
amounts of IL-9 were detected in these
supernatants, but there were no corre-
lations between Th2 cytokines (IL-4, IL-
5, and IL-13) and IL-9 concentrations
(data not shown). These results implied
that IL-9 might not be produced by Th2
cells. Next, we used DO11.10 (OVA-
specific TCR-transgenic) mice. Large
amounts of IL-9 were detected in the
cell culture supernatants for mice that
had received OVA patch application
(Figure 1a). We also performed intra-
cellular cytokine staining at 24 hours
after OVA reactivation culture of lymph
node cells in order to examine these
IL-9-producing CD4 T cells. As shown
in Figure 1b, the CD4 T cells that
produced IL-9 did not co-produce IL-4,
IFN-g, IL-17, or IL-10. Moreover, mice
receiving OVA patch application
showed more IL-9-producing CD4 T
cells after OVA reactivation culture
than control mice receiving PBS appli-
cation (Figure 1c). Thus, these results
demonstrated that epicutaneous sensi-
tization with a protein antigen could
generate a small but significant number
of Th9 cells.
IL-9 has recently attracted renewed
interest because of the identification of
Th9 cells. IL-9 is a member of a
common g-chain-receptor cytokine
family whose targets include mast cells,
T cells, and antigen-presenting cells
(Noelle and Nowak, 2010). Previously,
focus was placed upon the effects of
IL-9 for regulating an effector phase,
especially for allergic reactions. For
example, there have been many reports
showing that IL-9 could enhance air-
way remodeling and perpetuate
chronic lung inflammation, thus con-
tributing to the pathogenesis of asthma
(Soroosh and Doherty, 2009). In con-
trast, the influence of IL-9 on the
sensitization phase has received much
less attention. Forbes et al. (2008)
reported that intestinal IL-9 overexpres-
sion predisposed to oral antigen
sensitization. Dodd et al. (2009) de-
monstrated that depletion of IL-9 during
the sensitization phase of syncytial virus
infection suppressed a Th2 response.
Arendse et al. (2005) showed that IL-9
could influence the Th dichotomy in
Leishmaniasis by promoting deleterious
Th2 responses in BALB/c mice. Because
epicutaneous sensitization with protein
antigen induces a predominant Th2
response, we explored the effects of
IL-9 on epicutaneous sensitization.
Groups of BALB/c mice received
daily OVA patch application on days
1–5 along with intraperitoneal injection
of either IL-9 (100ml; 2mg ml–1) or PBS
(100ml) on days 0, 4, and 8. After 10
days, we prepared lymph node cell
OVA reactivation cultures, and cyto-
kine contents in supernatants were
determined by ELISA at 48 hours. As
shown in Figure 2a, cells from mice that
received IL-9 had increased amounts of
IL-5 and IL-13 in culture supernatants as
compared with control mice that re-
ceived PBS. Next, groups of BALB/c
mice received an intraperitoneal injec-
tion of either an anti-IL-9 antibody
(100mg) from BioLegend (San Diego,
CA) or an isotype control (Armenian
Hamster IgG) 1 day before they receiv-
ed OVA patch application on days 1–5.
Cells from mice that received anti-IL-9
had much lower IL-5 and IL-13 culture
supernatant concentrations than cells
from mice that received an isotype
control (Figure 2b). In addition, mice that
received anti-IL-9 during the sensitization
course also showed significantly lower
serum levels of OVA-specific IgE and
OVA-specific IgG1 after the OVA chal-
lenge course than the mice that received
the isotype control, whereas the serum
levels of OVA-specific IgG2a were com-
parable between these two groups
(Figure 2c). Collectively, these resultsAbbreviations: NKT cell, natural killer T cell; OVA, ovalbumin; Th, T helper
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demonstrate that IL-9 promotes the Th2
response induced by epicutaneous sensi-
tization with a protein antigen.
Our results are in agreement with
previous reports that showed enhanced
Th2 responses due to IL-9 in different
model systems (Forbes et al., 2008;
Dodd et al., 2009). The cellular sources
of IL-9 include mast cells, natural killer
T (NKT) cells, and T cells (Noelle and
Nowak, 2010). Although we could not
exclude the possibility that mast cells or
NKT cells might have contributed to
IL-9 production in regional lymph
nodes, we propose that differentiated
Th9 cells were the main source of
IL-9 after epicutaneous sensitization,
as IL-9 mRNA expression in regional
lymph nodes at 1–4 days after
epicutaneous sensitization was only
marginally detectable (data not shown).
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Figure 1. Induction of T helper type 9 (Th9) cells by epicutaneous sensitization with ovalbumin (OVA). Groups of BALB/c (n¼5) (a) or DO11.10 (n¼ 5; a–c)
mice were sensitized by patch application with OVA solution or phosphate-buffered saline (PBS) control. After 10 days, draining lymph nodes were harvested.
(a) The IL-9 contents of supernatants of in vitro reactivation cultures of the pooled draining lymph node cells were determined by ELISA. (b, c) CD4 T cells were
purified after in vitro OVA reactivation cultures for 24 hours with the addition of monesin for the last 4 hours. In addition, intracellular staining for various
cytokines was performed and cells were analyzed by flow cytometry. APC, allophycocyanin; PE, phycoerythrin.
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We hypothesize that epicutaneous sen-
sitization induces the generation of Th9
cells, which promote a Th2 response by
the rapid release of IL-9 once they have
completed differentiation (Tan et al.,
2010). Studies are underway in our
laboratory to explore the mechanisms
of how IL-9 could promote these Th2
responses.
To the best of our knowledge, this is
previously unreported, demonstrating
the generation of Th9 cells in vivo. In
addition, we provide evidence showing
that IL-9 has a critical role in promoting
a Th2 response induced by epicuta-
neous sensitization with a protein
antigen.
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Figure 2. IL-9 promotes the T helper type 2 (Th2) response induced by epicutaneous sensitization with ovalbumin (OVA). Groups of BALB/c mice
(n¼5) received phosphate-buffered saline (PBS) or OVA patch application on days 1–5 along with (a) intraperitoneal (i.p.) IL-9 or PBS on days 0, 4, and 8 and
(b) i.p. anti-IL-9 antibody or isotype control on day 0. After 10 days, the IL-5 and IL-13 contents of supernatants of in vitro OVA reactivation culture were
determined. (c) Groups of BALB/c mice (n¼ 10) received another OVA challenge course on days 22–26. On day 29, blood was obtained and serum
levels of OVA-specific IgE, IgG1, and IgG2a were determined by ELISA. T-test with unequal variance was adopted to test the difference between two groups;
the P-values for IgE, IgG1, and IgG2a are 0.014, 0.015, and 0.440, respectively. OD, optical density.
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